Year-long trend in glycated hemoglobin levels in patients with type 2 diabetes during the covid-19 pandemic

Jonghwa Jin, Seong Wook Lee, Won Ki Lee, Jae Han Jeon, Jung Guk Kim, In Kyu Lee, Yeon Kyung Choi, Keun Gyu Park

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

It has been suggested that the coronavirus disease 2019 (COVID-19) pandemic has had a negative impact on glycemic control in patients with type 2 diabetes mellitus (T2DM). However, no study has examined yearly trends in glycated hemoglobin (HbA1c) levels after the start of the COVID-19 outbreak. Here, we performed a retrospective analysis of HbA1c concentrations during the early period of the COVID-19 outbreak (COVID-19 cohort) and then compared the yearly trend in the mean HbA1c level, along with fluctuations in HbA1c levels, with those during previous years (non-COVID-19 cohorts). We observed that the mean HbA1c level in patients with T2DM increased during the first 6 months of the COVID-19 outbreak. After 6 months, HbA1c levels in the COVID-19 cohort returned to levels seen in the non-COVID-19 cohorts. The data suggest that vulnerable patients with T2DM should be monitored closely during the early period of a pandemic to ensure they receive appropriate care.

Original languageEnglish
Pages (from-to)1142-1146
Number of pages5
JournalEndocrinology and Metabolism
Volume36
Issue number5
DOIs
StatePublished - Oct 2021

Keywords

  • COVID-19
  • Diabetes mellitus
  • Glycated hemoglobin A
  • Physical distancing

Fingerprint

Dive into the research topics of 'Year-long trend in glycated hemoglobin levels in patients with type 2 diabetes during the covid-19 pandemic'. Together they form a unique fingerprint.

Cite this